Skip to content
value.today

Nihon Chouzai Co., Ltd.

3341.TUnlisted company
$295 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$2.6 B
Mar-2021 ending year
value.today research
Net income
$33 M
1.3% margin
value.today research
Employees
—

Nihon Chouzai Co., Ltd. in brief

Nihon Chouzai Co., Ltd. is an unlisted company in the Pharmaceutical industry, based in Japan. It was founded in 1980. In the year to Mar 2021 it had sales of $2.6 B and a net profit of $33 M, about 1 cents of profit for every dollar of sales.

Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.

Nihon Chouzai Co., Ltd. timeline

5 events, 1980–2024
  1. 1980
  2. 🏁
    · approximate
    Founded
  3. 2005
  4. ⊕
    · approximate
    Nihon Generic became a subsidiary
  5. 2006
  6. 🔔
    Initial public offering on Tokyo Stock Exchange as 3341
  7. 2013
  8. ⊕
    · approximate
    Choseido Pharmaceutical became a subsidiary
  9. 2024
  10. 📍
    · approximate
    Headquarters moved to Shiba

Events of Nihon Chouzai Co., Ltd. from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Nihon Chouzai Co., Ltd.

Acquisitions and changes
No longer listed: it is not in the Japan Exchange Group's list of issues listed on the Tokyo Stock Exchange (checked 14 November 2026).

Market cap history

$0 M$142 M$284 M$426 M$568 M20202021202220232024

World rank over time

▼ down 5,079 places since 2020
2020-01-01: #10786#10,78620202021-01-01: #11845#11,84520212022-01-07: #15495#15,49520222022-12-25: #16515#16,51520222023-07-30: #16789#16,78920232024-01-05: #15865#15,8652024

Rank in Japan: #1,095 (Jan 2020) · #1,191 (Jan 2021) · #1,246 (Jan 2022) · #1,304 (Dec 2022) · #1,399 (Jul 2023) · #1,322 (Jan 2024)

Annual results

Revenue
$2.6 B
Operating income
—
Net income
$33 M

Mar-2021 ending year

Acquisitions and funding#

1 acquisitions

Businesses it acquired

Acquisitions by Nihon Chouzai Co., Ltd.
AcquiredAcquisition dateCompletionPriceStakeSource
Choseido PharmaceuticalApr 2013———Wikidata

How Nihon Chouzai Co., Ltd. compares in Pharmaceutical

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Nihon Chouzai Co., Ltd.🇯🇵$295 M—1.3%—
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

How current the figures are

Market cap:
Jan 5, 2024 (last known)
Annual results:
Mar-2021 ending year
Balance sheet:
Mar-2021 ending year
Profile updated:
Nov 14, 2026

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Nihon Chouzai Co., Ltd.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Nihon Chouzai Co., Ltd.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Nihon Chouzai Co., Ltd.? Suggest a correction